ataprost has been researched along with Heart-Failure* in 3 studies
3 other study(ies) available for ataprost and Heart-Failure
| Article | Year |
|---|---|
[Acute effects of prostaglandin I2 analogue (OP-41483, alpha-CD) on the disturbances of pulmonary circulation with right ventricular failure].
Topics: Aged; Chronic Disease; Epoprostenol; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Circulation; Respiratory Insufficiency | 1988 |
[Effects of OP-41483.alpha-CD, a prostacyclin analog, in the treatment of congestive refractory heart failure--efficacy as a vasodilator].
Topics: Adult; Aged; Cyclodextrins; Drug Evaluation; Epoprostenol; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vasodilator Agents | 1986 |
Vasodilator therapy with a new stable prostacyclin analog, OP-41483, for congestive heart failure due to coronary artery disease and comparison of hemodynamic effects and platelet aggregation with nitroprusside.
A new stable prostacyclin analog, OP-41483, was used in patients with severe congestive heart failure (CHF) due to coronary artery disease and compared with nitroprusside. During infusion of both drugs, mean brachial arterial pressure, total pulmonary resistance, pulmonary artery wedge pressure and systemic vascular resistance decreased significantly. Cardiac index and stroke index also increased significantly. Platelet aggregation did not change significantly during nitroprusside but decreased significantly with OP-41483 infusion. Thus, this analog may be useful for treatment of patients with CHF due to coronary artery disease. Topics: Aged; Coronary Disease; Epoprostenol; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Platelet Aggregation; Prostaglandins, Synthetic | 1986 |